Prescott Deininger is a molecular geneticist with a focus on genetic instability of the human genome in cancer. His work focuses primarily on mobile elements in the human genome and how they serve as risk factors for increased genetic instability. Dr. Deininger has served on the Board of Scientific Counselors for the NIEHS National Toxicology Program and the National Academies Committee for Disaster Resilience in the Biomedical Research Enterprise. He is an executive editor for Analytical Biochemistry and serves on numerous journal editorial boards. Dr.

Dr. Wei Chen is a genetic epidemiologist of cardiovascular disease and has been working with the Bogalusa Heart Study as a senior investigator for 20 years. He has a broad background and experience in epidemiology, genetics and epigenetics of cardiovascular disease, diabetes, metabolic syndrome and hypertension, fetal and childhood origins of chronic diseases, epidemiologic methodology, and longitudinal analysis models. As principal investigator, he has been awarded 12 NIH and American Heart Association-funded research projects in the above research areas. Dr.

Chung-Shiuan Chen is a biostatistician serving as a data manager for several studies. She performs data quality control, prepares analytical datasets, and analyzes data in the focus of cardiovascular diseases. She works with other study groups by providing summary data and also assists junior faculty by providing suggestions regarding the statistical methods Computer Packages for Epidemiology, which focuses on both data management and data analysis using SAS and Stata.

As a clinician-investigator trained in epidemiology and internal medicine, Dr. Lydia Bazzano has expertise in a broad range of clinical research with a focus on cardiovascular disease and its risk factors, with an emphasis on the role of cardio-metabolic factors, including diet, obesity, lipids and glucose, in the development of vascular disease and its consequences over the life course.